Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
5.93
-0.36 (-5.72%)
At close: Sep 17, 2025, 4:00 PM EDT
6.00
+0.07 (1.18%)
After-hours: Sep 17, 2025, 6:10 PM EDT
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $350.31 million as of September 17, 2025. Its market cap has decreased by -67.96% in one year.
Market Cap
350.31M
Enterprise Value
91.07M
1-Year Change
-67.96%
Ranking
Category
Stock Price
$5.93
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has decreased from $829.45M to $350.31M, a decrease of -57.77%. That is a compound annual growth rate of -16.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 371.58M | -47.61% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
| Jan 8, 2021 | 829.45M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |